NYSE$ENOV
Enovis Corp · Q1 2021 earnings
Q1 2021 earnings · · Investor relations
Briefing
Reported an increase in sales and adjusted EPS, driven by strong performance in both ESAB and MedTech segments.
Colfax Corporation reported strong first-quarter results with an 8% increase in sales and a 16% rise in adjusted EPS. The company's performance was driven by increased demand and margin expansion in ESAB, as well as improved market conditions and share gains in the MedTech segment. Colfax is raising the low-end of its adjusted 2021 EPS guidance range to $2.05-$2.15.
- Reported $0.19 EPS from continuing operations and achieved $0.44 of adjusted EPS.
- Grew sales 8% including organic sales-per-day growth of 9%.
- Announced expanded fast-growing foot & ankle business with the acquisition of MedShape.
- Raising low-end of adjusted 2021 EPS guidance range to $2.05-$2.15.
Headline financials
Revenue & EPS history
Enovis · Revenue · Quarterly
$879M
Revenue by segment
Enovis · $131M total across 1 segment · Q2 2022
- Reconstructive$131M—100.0%
Forward guidance
For the second quarter of 2021, Colfax expects adjusted earnings of $0.48 to $0.53 per diluted share. This guidance range reflects the recent equity issuance and senior note redemptions.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2021
+1.6%
Avg return
Earnings day
+1.3%
Avg return
5 days after
+0.1%
Avg return
30 days after
52%
33 / 64 earnings
Positive
+21.3%
Q3 2011
Best reaction
-18.7%
Q1 2016
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +9.7% | +4.0% | -4.5% | |
| Q4 2025 | +13.8% | +13.3% | -2.2% | |
| Q3 2025 | -9.7% | +0.1% | -14.2% | |
| Q1 2025 | -2.9% | +9.1% | -7.2% | |
| Q4 2024 | -4.9% | -10.1% | -10.3% | |
| Q3 2024 | +10.6% | +9.3% | +10.0% | |
| Q2 2024 | +4.0% | +1.0% | +3.5% | |
| Q1 2024 | -7.5% | -5.7% | -9.3% | |
| Q4 2023 | +4.3% | +2.0% | -0.1% | |
| Q3 2023 | +4.0% | +3.2% | +8.8% | |
| Q2 2023 | -5.6% | -8.1% | -10.0% | |
| Q1 2023 | -1.8% | -3.7% | -3.9% | |
| Q4 2022 | -9.6% | -6.4% | -18.9% | |
| Q3 2022 | -3.4% | +7.4% | +15.9% | |
| Q2 2022 | -3.7% | -4.4% | -17.5% | |
| Q1 2022 | +5.7% | +5.9% | +7.4% | |
| Q4 2021 | +0.9% | +2.8% | -3.7% | |
| Q3 2021 | +0.4% | -1.4% | -14.9% | |
| Q2 2021 | +3.6% | +2.1% | +8.5% | |
| Q1 2021 | -1.1% | -5.9% | -3.2% | |
| Q4 2020 | +13.7% | +17.2% | +16.8% | |
| Q3 2020 | -4.1% | +3.0% | +30.8% | |
| Q2 2020 | +6.8% | +13.0% | +8.1% | |
| Q1 2020 | +14.6% | +6.6% | +33.4% | |
| Q4 2019 | +2.8% | -5.1% | -55.3% | |
| Q3 2019 | +9.6% | +11.5% | +6.0% | |
| Q2 2019 | +7.9% | +5.3% | +15.1% | |
| Q1 2019 | -5.5% | -6.5% | -4.7% | |
| Q4 2018 | +5.3% | +6.8% | +15.0% | |
| Q3 2018 | -0.3% | +0.8% | -12.5% | |
| Q2 2018 | +5.5% | +0.8% | +12.9% | |
| Q1 2018 | +2.2% | +5.3% | +1.1% | |
| Q4 2017 | -8.5% | -14.2% | -11.2% | |
| Q3 2017 | -12.7% | -13.7% | -14.0% | |
| Q2 2017 | +1.1% | +0.9% | -4.3% | |
| Q1 2017 | +1.9% | +2.4% | +7.4% | |
| Q4 2016 | +2.2% | -0.5% | -5.0% | |
| Q3 2016 | +7.8% | +5.4% | +26.9% | |
| Q2 2016 | +0.0% | -3.2% | +3.4% | |
| Q1 2016 | -18.7% | — | — | |
| Q4 2015 | +18.9% | — | — | |
| Q3 2015 | -6.5% | — | — | |
| Q2 2015 | -5.1% | — | — | |
| Q1 2015 | -0.8% | — | — | |
| Q4 2014 | -0.9% | — | — | |
| Q3 2014 | -5.1% | — | — | |
| Q2 2014 | -6.9% | — | — | |
| Q1 2014 | -3.4% | — | — | |
| Q4 2013 | +7.0% | — | — | |
| Q3 2013 | +0.0% | — | — | |
| Q2 2013 | -0.1% | — | — | |
| Q1 2013 | +4.5% | — | — | |
| Q4 2012 | -5.8% | — | — | |
| Q3 2012 | -2.7% | — | — | |
| Q2 2012 | +5.2% | — | — | |
| Q1 2011 | -5.7% | — | — | |
| Q1 2012 | +1.3% | — | — | |
| Q4 2011 | -1.9% | — | — | |
| Q3 2011 | +21.3% | — | — | |
| Q2 2011 | +16.2% | — | — | |
| Q4 2010 | +16.2% | — | — | |
| Q2 2010 | +16.2% | — | — | |
| Q3 2010 | +1.0% | — | — | |
| Q1 2010 | +0.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro